par Souery, Daniel 
;Serretti, Alessandro;Calati, Raffaella;Oswald, Pierre ;Massat, Isabelle ;Konstantinidis, Anastasios;Linotte, Sylvie ;Bollen, Joseph;Demyttenaere, Koen;Kasper, Siegfried;Lecrubier, Yves;Montgomery, Stuart;Zohar, Joseph;Mendlewicz, Julien
Référence Journal of clinical psychopharmacology, 31, 4, page (512-516)
Publication Publié, 2011-08
;Serretti, Alessandro;Calati, Raffaella;Oswald, Pierre ;Massat, Isabelle ;Konstantinidis, Anastasios;Linotte, Sylvie ;Bollen, Joseph;Demyttenaere, Koen;Kasper, Siegfried;Lecrubier, Yves;Montgomery, Stuart;Zohar, Joseph;Mendlewicz, Julien Référence Journal of clinical psychopharmacology, 31, 4, page (512-516)
Publication Publié, 2011-08
Article révisé par les pairs
| Résumé : | The management of treatment-resistant depression is a much debated issue. In particular, the evidence supporting the commonly suggested sequential use of antidepressants from 2 different pharmacological classes is weak. This retrospective study was undertaken to investigate whether there is a better response in nonresponders switched to a different class of antidepressants (across-class) compared with nonresponders switched to an antidepressant from the same class (within-class). |
